CN1425466A - 一组新型抗肿瘤基因治疗药物短干扰核糖核酸 - Google Patents
一组新型抗肿瘤基因治疗药物短干扰核糖核酸 Download PDFInfo
- Publication number
- CN1425466A CN1425466A CN 02159031 CN02159031A CN1425466A CN 1425466 A CN1425466 A CN 1425466A CN 02159031 CN02159031 CN 02159031 CN 02159031 A CN02159031 A CN 02159031A CN 1425466 A CN1425466 A CN 1425466A
- Authority
- CN
- China
- Prior art keywords
- sirna
- seq
- auc
- sirnas
- uag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02159031 CN1225286C (zh) | 2002-12-27 | 2002-12-27 | 一组新型抗肿瘤基因治疗药物短干扰核糖核酸 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02159031 CN1225286C (zh) | 2002-12-27 | 2002-12-27 | 一组新型抗肿瘤基因治疗药物短干扰核糖核酸 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1425466A true CN1425466A (zh) | 2003-06-25 |
CN1225286C CN1225286C (zh) | 2005-11-02 |
Family
ID=4753220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02159031 Expired - Fee Related CN1225286C (zh) | 2002-12-27 | 2002-12-27 | 一组新型抗肿瘤基因治疗药物短干扰核糖核酸 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1225286C (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1313159C (zh) * | 2005-06-03 | 2007-05-02 | 陈志南 | HAb18G/CD147分子小片段干涉RNA药物及其用途 |
CN100352922C (zh) * | 2003-08-07 | 2007-12-05 | 徐根兴 | 抑制人VEGF基因的表达的siRNA和表达载体及其在制药中的应用 |
CN100368423C (zh) * | 2003-11-21 | 2008-02-13 | 杭州新瑞佳生物医药技术开发有限公司 | 有效杀伤肿瘤细胞的针对PLK1 mRNA的小干扰核糖核酸分子(SiRNA)、其混合物及用途 |
CN100374573C (zh) * | 2006-04-14 | 2008-03-12 | 中国医学科学院医药生物技术研究所 | 一种可稳定表达VEGF shRNA的载体pCD-VEGF |
CN1704123B (zh) * | 2004-06-01 | 2010-06-02 | 广州拓谱基因技术有限公司 | 用于体内预防或治疗呼吸系统疾病的小干扰rna制剂及其筛选方法 |
CN101921292A (zh) * | 2010-06-22 | 2010-12-22 | 中国医学科学院医药生物技术研究所 | 一种新型siRNA化学修饰单体及其制备方法和用途 |
CN101591655B (zh) * | 2009-06-01 | 2011-01-19 | 中山大学中山眼科中心 | 一种特异性阻断PKCα信号传递的siRNA及其应用 |
CN103417988A (zh) * | 2013-07-20 | 2013-12-04 | 浙江大学 | Cdk2基因在制备白血病诱导分化治疗药物中的应用 |
CN107541513A (zh) * | 2016-06-28 | 2018-01-05 | 深圳先进技术研究院 | 用于沉默cd317的小分子干扰rna、重组载体、药物及其应用 |
-
2002
- 2002-12-27 CN CN 02159031 patent/CN1225286C/zh not_active Expired - Fee Related
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100352922C (zh) * | 2003-08-07 | 2007-12-05 | 徐根兴 | 抑制人VEGF基因的表达的siRNA和表达载体及其在制药中的应用 |
CN100368423C (zh) * | 2003-11-21 | 2008-02-13 | 杭州新瑞佳生物医药技术开发有限公司 | 有效杀伤肿瘤细胞的针对PLK1 mRNA的小干扰核糖核酸分子(SiRNA)、其混合物及用途 |
CN1704123B (zh) * | 2004-06-01 | 2010-06-02 | 广州拓谱基因技术有限公司 | 用于体内预防或治疗呼吸系统疾病的小干扰rna制剂及其筛选方法 |
CN1313159C (zh) * | 2005-06-03 | 2007-05-02 | 陈志南 | HAb18G/CD147分子小片段干涉RNA药物及其用途 |
CN100374573C (zh) * | 2006-04-14 | 2008-03-12 | 中国医学科学院医药生物技术研究所 | 一种可稳定表达VEGF shRNA的载体pCD-VEGF |
CN101591655B (zh) * | 2009-06-01 | 2011-01-19 | 中山大学中山眼科中心 | 一种特异性阻断PKCα信号传递的siRNA及其应用 |
CN101921292A (zh) * | 2010-06-22 | 2010-12-22 | 中国医学科学院医药生物技术研究所 | 一种新型siRNA化学修饰单体及其制备方法和用途 |
CN101921292B (zh) * | 2010-06-22 | 2013-11-13 | 中国医学科学院医药生物技术研究所 | 一种新型siRNA化学修饰单体及其制备方法和用途 |
CN103417988A (zh) * | 2013-07-20 | 2013-12-04 | 浙江大学 | Cdk2基因在制备白血病诱导分化治疗药物中的应用 |
CN107541513A (zh) * | 2016-06-28 | 2018-01-05 | 深圳先进技术研究院 | 用于沉默cd317的小分子干扰rna、重组载体、药物及其应用 |
CN107541513B (zh) * | 2016-06-28 | 2020-11-17 | 深圳宾德生物技术有限公司 | 用于沉默cd317的小分子干扰rna、重组载体、药物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1225286C (zh) | 2005-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210207137A1 (en) | Rna-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor | |
Wu et al. | 2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity | |
US8889643B2 (en) | Isoform of bruton's tyrosine kinase (BTK) protein | |
Tanudji et al. | Gene silencing of CENP-E by small interfering RNA in HeLa cells leads to missegregation of chromosomes after a mitotic delay | |
CN113633656A (zh) | 包含微小核糖核酸作为活性成分的用于治疗癌症的药物组合物 | |
EP2374884A2 (en) | Human miRNAs isolated from mesenchymal stem cells | |
EP2316491A1 (en) | Cell proliferation inhibitor | |
Li et al. | Long non-coding RNA SNHG16 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer via sponging miR-200a-3p | |
JP2014533953A (ja) | 治療用rnaスイッチ組成物及び使用方法 | |
CN1425466A (zh) | 一组新型抗肿瘤基因治疗药物短干扰核糖核酸 | |
US20220282250A1 (en) | Long non-coding rna in cancer | |
CN108004322A (zh) | 一种lncRNA在诊断和/或治疗肺腺癌中的应用 | |
Laposa et al. | Recapitulation of the Cellular Xeroderma Pigmentosum-Variant Phenotypes Using Short Interfering RNA for DNA Polymerase Η | |
Cai et al. | Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell (GL15) | |
WO2011040613A1 (ja) | 腫瘍治療剤 | |
Kadekar et al. | Synthetic design of asymmetric miRNA with an engineered 3′ overhang to improve strand selection | |
CN101445534A (zh) | 一种高效的siRNA在制备抑制肿瘤迁移药物中的用途 | |
CN112608998A (zh) | 人mt-nd1的用途及相关产品 | |
CN112375823B (zh) | miRNA抑制剂在制备治疗和/或预防淋巴瘤的药物中的应用 | |
Ma et al. | Exosomes miRNA-499a-5p targeted CD38 to alleviate anthraquinone induced cardiotoxicity: experimental research | |
CN101220359B (zh) | 一种抑制bak基因表达的siRNA序列 | |
CN101892235B (zh) | 用于诱导白血病细胞分化的小分子rna及其应用 | |
CN117467664B (zh) | 一种靶向鸡mbnl1基因的反义寡核苷酸及其应用 | |
CN115717142B (zh) | silncRNA16及其治疗铂类耐药肿瘤中的用途 | |
CN103937800A (zh) | 靶向多基因的siRNA分子及其抑制肿瘤的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Jiangsu Huililong Plastic Industry Group Co., Ltd. Assignor: Biomedical Technology Inst., Chinese Academy of Medical Sciences Contract fulfillment period: 2009.2.10 to 2019.2.10 contract change Contract record no.: 2009320000447 Denomination of invention: Short interference ribonucleic acid as novel anti-tumor gene therapeutic medicine Granted publication date: 20051102 License type: exclusive license Record date: 2009.3.19 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.2.10 TO 2019.2.10; CHANGE OF CONTRACT Name of requester: JIANGSU HUILILONG PLASTIC INDUSTRY GROUP CO.,LTD. Effective date: 20090319 |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |